Proto Labs (PRLB)
(Delayed Data from NYSE)
$31.42 USD
-0.53 (-1.66%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $31.44 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 103 | 80 | 78 | 162 | 161 |
Receivables | 75 | 80 | 81 | 58 | 57 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 14 | 14 | 13 | 11 | 10 |
Other Current Assets | 9 | 13 | 11 | 11 | 8 |
Total Current Assets | 201 | 187 | 183 | 242 | 236 |
Net Property & Equipment | 254 | 258 | 280 | 283 | 264 |
Investments & Advances | 8 | 26 | 14 | 59 | 13 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 300 | 305 | 439 | 143 | 146 |
Deposits & Other Assets | 5 | 5 | 4 | 5 | 3 |
Total Assets | 772 | 802 | 929 | 744 | 674 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 16 | 17 | 25 | 18 | 17 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 18 | 1 | 1 | 0 |
Accrued Expenses | 32 | 35 | 26 | 28 | 26 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 1 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 50 | 72 | 55 | 50 | 48 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 19 | 26 | 36 | 34 | 26 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 1 | 0 | 1 | 2 | 0 |
Other Non-Current Liabilities | 5 | 4 | 6 | 6 | 5 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 77 | 105 | 100 | 100 | 88 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 467 | 474 | 469 | 285 | 268 |
Retained Earnings | 256 | 258 | 377 | 363 | 325 |
Other Equity | -28 | -34 | -17 | -3 | -7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 695 | 698 | 828 | 644 | 586 |
Total Liabilities & Shareholder's Equity | 772 | 802 | 929 | 744 | 674 |
Total Common Equity | 695 | 698 | 828 | 644 | 586 |
Shares Outstanding | 25.70 | 27.10 | 27.50 | 26.70 | 26.70 |
Book Value Per Share | 27.05 | 25.74 | 30.13 | 24.13 | 21.94 |
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 103 | 103 | 86 | 85 |
Receivables | NA | 75 | 79 | 76 | 78 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 14 | 14 | 14 | 14 |
Other Current Assets | NA | 9 | 9 | 9 | 11 |
Total Current Assets | NA | 201 | 205 | 185 | 189 |
Net Property & Equipment | NA | 254 | 243 | 249 | 254 |
Investments & Advances | NA | 8 | 12 | 16 | 20 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 300 | 301 | 302 | 304 |
Deposits & Other Assets | NA | 5 | 4 | 5 | 5 |
Total Assets | NA | 772 | 784 | 777 | 791 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 16 | 18 | 16 | 20 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 17 | 17 | 17 |
Accrued Expenses | NA | 32 | 37 | 32 | 38 |
Income Taxes Payable | NA | 0 | 1 | 0 | 2 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 50 | 75 | 66 | 78 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 19 | 17 | 21 | 23 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 1 | 1 | 1 | 0 |
Other Non-Current Liabilities | NA | 5 | 5 | 5 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 77 | 99 | 95 | 108 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 467 | 464 | 465 | 465 |
Retained Earnings | NA | 256 | 251 | 247 | 251 |
Other Equity | NA | -28 | -30 | -29 | -33 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 695 | 685 | 683 | 683 |
Total Liabilities & Shareholder's Equity | NA | 772 | 784 | 777 | 791 |
Total Common Equity | 0 | 695 | 685 | 683 | 683 |
Shares Outstanding | 25.70 | 25.70 | 26.10 | 26.20 | 26.20 |
Book Value Per Share | 0.00 | 27.05 | 26.24 | 26.06 | 26.07 |